Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2008) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.204 Q1 | 99 | 28 | 53 | 5091 | 239 | 50 | 3.78 | 181.82 |  |
| 2 | Natural Product Reports | journal | 2.918 Q1 | 211 | 58 | 167 | 8919 | 1101 | 162 | 6.38 | 153.78 | |
| 3 | Issues in Toxicology | book series | 0.114 Q4 | 18 | 25 | 26 | 3368 | 2 | 24 | 0.08 | 134.72 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.986 Q2 | 54 | 43 | 144 | 5144 | 459 | 144 | 3.44 | 119.63 | |
| 5 | Critical Reviews in Toxicology | journal | 2.095 Q1 | 129 | 44 | 97 | 5208 | 694 | 91 | 7.31 | 118.36 | |
| 6 | Expert Opinion on Therapeutic Targets | journal | 1.533 Q1 | 106 | 127 | 307 | 12944 | 1104 | 285 | 3.83 | 101.92 | |
| 7 | Expert Opinion on Drug Delivery | journal | 0.942 Q1 | 133 | 98 | 201 | 9837 | 652 | 190 | 3.37 | 100.38 | |
| 8 | Expert Opinion on Drug Discovery | journal | 0.319 Q3 | 84 | 106 | 197 | 9775 | 201 | 194 | 1.02 | 92.22 | |
| 9 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.952 Q2 | 100 | 123 | 187 | 10962 | 769 | 182 | 3.74 | 89.12 | |
| 10 | Expert Opinion on Therapeutic Patents | journal | 0.505 Q3 | 88 | 102 | 350 | 8712 | 432 | 339 | 1.18 | 85.41 | |
| 11 | Expert Opinion on Biological Therapy | journal | 1.198 Q1 | 102 | 171 | 423 | 14412 | 1417 | 421 | 3.76 | 84.28 | |
| 12 | CNS Neuroscience and Therapeutics | journal | 91 | 31 | 0 | 2582 | 0 | 0 | 0.00 | 83.29 | | |
| 13 | BioDrugs | journal | 1.121 Q1 | 79 | 38 | 123 | 3093 | 420 | 117 | 2.97 | 81.39 | |
| 14 | Molecular Diagnosis and Therapy | journal | 0.704 Q2 | 68 | 38 | 146 | 2967 | 342 | 141 | 2.46 | 78.08 | |
| 15 | Expert Review of Vaccines | journal | 1.038 Q1 | 105 | 137 | 255 | 10660 | 762 | 232 | 2.97 | 77.81 | |
| 16 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 294 | 742 | 21461 | 1699 | 724 | 2.45 | 73.00 | |
| 17 | Toxin Reviews | journal | 0.174 Q4 | 54 | 19 | 69 | 1383 | 32 | 65 | 0.56 | 72.79 | |
| 18 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 117 | 173 | 445 | 12481 | 1750 | 418 | 3.98 | 72.14 | |
| 19 | Expert Review of Clinical Pharmacology | journal | 60 | 71 | 0 | 5038 | 0 | 0 | 0.00 | 70.96 | | |
| 20 | Current Opinion in Investigational Drugs | journal | 1.135 Q1 | 83 | 126 | 393 | 8936 | 1223 | 361 | 3.56 | 70.92 | |
| 21 | Current Opinion in Molecular Therapeutics | journal | 1.069 Q1 | 67 | 71 | 223 | 4806 | 612 | 201 | 3.10 | 67.69 | |
| 22 | Clinical Pharmacokinetics | journal | 1.480 Q1 | 184 | 62 | 236 | 4132 | 1372 | 224 | 5.00 | 66.65 | |
| 23 | Drug Discovery Today: Disease Mechanisms | journal | 0.208 Q4 | 28 | 38 | 197 | 2432 | 84 | 175 | 0.41 | 64.00 | |
| 24 | Neuropsychopharmacology | journal | 3.385 Q1 | 249 | 303 | 770 | 19353 | 5141 | 742 | 6.37 | 63.87 | |
| 25 | Current Opinion in Drug Discovery and Development | journal | 1.394 Q1 | 85 | 74 | 214 | 4597 | 883 | 196 | 4.35 | 62.12 | |
| 26 | Trends in Pharmacological Sciences | journal | 4.697 Q1 | 244 | 88 | 301 | 5411 | 2916 | 282 | 9.90 | 61.49 | |
| 27 | Biomarkers in Medicine | journal | 56 | 50 | 0 | 3046 | 0 | 0 | 0.00 | 60.92 | | |
| 28 | Therapeutic Advances in Neurological Disorders | journal | 68 | 18 | 0 | 1083 | 0 | 0 | 0.00 | 60.17 | | |
| 29 | Cardiovascular Therapeutics | journal | 54 | 32 | 0 | 1922 | 0 | 0 | 0.00 | 60.06 | | |
| 30 | Mutagenesis | journal | 1.133 Q1 | 102 | 61 | 171 | 3497 | 530 | 165 | 3.07 | 57.33 | |
| 31 | Neuropharmacology | journal | 1.797 Q1 | 191 | 296 | 754 | 16460 | 2883 | 752 | 3.65 | 55.61 | |
| 32 | Drug Discovery Today: Disease Models | journal | 0.197 Q4 | 33 | 38 | 147 | 2088 | 67 | 131 | 0.49 | 54.95 | |
| 33 | Xenobiotica | journal | 0.535 Q3 | 89 | 92 | 237 | 5011 | 539 | 235 | 2.24 | 54.47 | |
| 34 | Drug Discovery Today | journal | 2.001 Q1 | 215 | 150 | 629 | 8163 | 3122 | 570 | 5.62 | 54.42 | |
| 35 | International Journal of Neuropsychopharmacology | journal | 1.843 Q1 | 125 | 109 | 258 | 5846 | 1071 | 226 | 3.88 | 53.63 | |
| 36 | Antiviral Chemistry and Chemotherapy | journal | 0.671 Q2 | 59 | 17 | 98 | 901 | 202 | 97 | 1.97 | 53.00 | |
| 37 | Pharmacogenomics | journal | 0.988 Q2 | 100 | 182 | 375 | 9640 | 1277 | 331 | 3.49 | 52.97 | |
| 38 | Future HIV Therapy | journal | 8 | 57 | 0 | 3017 | 0 | 0 | 0.00 | 52.93 | | |
| 39 | Drugs in R and D | journal | 0.455 Q3 | 54 | 43 | 127 | 2273 | 235 | 127 | 2.03 | 52.86 | |
| 40 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.145 Q4 | 5 | 11 | 44 | 581 | 12 | 39 | 0.27 | 52.82 | |
| 41 | Nature Reviews Drug Discovery | journal | 7.292 Q1 | 391 | 165 | 659 | 8590 | 5817 | 345 | 12.24 | 52.06 | |
| 42 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.641 Q2 | 57 | 29 | 112 | 1475 | 207 | 104 | 1.83 | 50.86 | |
| 43 | Toxicology and Industrial Health | journal | 0.261 Q3 | 69 | 53 | 133 | 2690 | 108 | 131 | 0.75 | 50.75 | |
| 44 | Tetrahedron | journal | 1.605 Q1 | 236 | 1322 | 3870 | 66367 | 12348 | 3840 | 3.06 | 50.20 | |
| 45 | Drug Discovery Today: Therapeutic Strategies | journal | 0.346 Q3 | 31 | 37 | 183 | 1854 | 145 | 167 | 0.81 | 50.11 | |
| 46 | Fundamental and Clinical Pharmacology | journal | 0.732 Q2 | 85 | 76 | 229 | 3644 | 585 | 223 | 2.37 | 47.95 | |
| 47 | Toxicological Sciences | journal | 1.752 Q1 | 207 | 260 | 970 | 12280 | 4526 | 937 | 4.79 | 47.23 | |
| 48 | Chinese Medicine | journal | 0.366 Q3 | 56 | 17 | 17 | 777 | 43 | 16 | 2.53 | 45.71 | |
| 49 | Nanotoxicology | journal | 1.034 Q1 | 107 | 25 | 26 | 1137 | 100 | 25 | 3.85 | 45.48 | |
| 50 | Drug Safety | journal | 1.221 Q1 | 140 | 104 | 287 | 4704 | 1111 | 249 | 3.42 | 45.23 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data